Tazeen Ahmad
Stock Analyst at B of A Securities
(0.35)
# 1967
Out of 5,270 analysts
223
Total ratings
42.11%
Success rate
6.24%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Neurocrine Bioscienc... | Maintains: Buy | 184 179 | 114.47 | 56.37% | 3 | Feb 7, 2025 | |
Prothena Corp | Maintains: Neutral | 26 22 | 14.38 | 52.99% | 5 | Dec 19, 2024 | |
4D Molecular Therape... | Maintains: Buy | 79 46 | 4.16 | 1005.77% | 3 | Dec 18, 2024 | |
KalVista Pharma | Initiates Coverage On: Buy | 22 | 10.85 | 102.76% | 1 | Dec 18, 2024 | |
PepGen | Downgrades: Underperform | 6 3 | 2.83 | 6.01% | 3 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 61 47 | 24.12 | 94.86% | 6 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 68 90 | 70.18 | 28.24% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 13 15 | 9.13 | 64.29% | 5 | Oct 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 307 314 | 243.64 | 28.88% | 2 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 48 52 | 52.36 | -0.69% | 7 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 11 6 | 7.21 | -16.78% | 14 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 175 191 | 151.76 | 25.86% | 8 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 125 150 | 111.4 | 34.65% | 7 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 10 2 | 3.21 | -37.69% | 6 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 25 29 | 15.12 | 91.8% | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 76 76 | 45.61 | 66.63% | 4 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 535 607 | 622.66 | -2.52% | 3 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 25 32 | 52.75 | -39.34% | 13 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 166 213 | 101.19 | 110.5% | 21 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 83 76 | 41.14 | 84.74% | 6 | May 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 26 22 | 18.14 | 21.28% | 13 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | 1.45 | 727.59% | 1 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 16 14 | 1.09 | 1184.4% | 2 | Apr 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 7 10 | 2.39 | 318.41% | 4 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 2 6 | 1.01 | 494.06% | 2 | Mar 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 15 | 5.89 | 154.67% | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 3 | n/a | n/a | 2 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 7 1 | 1.39 | -64.03% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 8 11 | 15.32 | -28.2% | 3 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 36 31 | n/a | n/a | 2 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 10 | 8.54 | 17.1% | 6 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 7 2 | 1.59 | 25.79% | 2 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 2 7 | 0.04 | 17400% | 3 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 90 20 | n/a | n/a | 2 | Dec 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 6 | 0.71 | 745.07% | 4 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 75 15 | 11.25 | 33.33% | 3 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 390 60 | 33.79 | 77.57% | 2 | Jun 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 23 | n/a | n/a | 2 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 16 | 1.12 | 1328.57% | 1 | Nov 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 2 | Oct 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 110 | 16.27 | 576.09% | 1 | Sep 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 20 | n/a | n/a | 2 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 13 5 | n/a | n/a | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 43 | 8.96 | 379.91% | 2 | Sep 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 45 47 | n/a | n/a | 2 | Aug 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | 6 | n/a | n/a | 4 | Apr 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 233 227 | n/a | n/a | 4 | Feb 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 3 | Sep 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underperform | n/a | n/a | n/a | 4 | Apr 25, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 330 300 | 4.16 | 7111.54% | 1 | Nov 2, 2018 |